首页> 外文OA文献 >Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays
【2h】

Broad-spectrum respiratory tract pathogen identification using resequencing DNA microarrays

机译:使用重测序DNA微阵列的广谱呼吸道病原体鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The exponential growth of pathogen nucleic acid sequences available in public domain databases has invited their direct use in pathogen detection, identification, and surveillance strategies. DNA microarray technology has offered the potential for the direct DNA sequence analysis of a broad spectrum of pathogens of interest. However, to achieve the practical attainment of this potential, numerous technical issues, especially nucleic acid amplification, probe specificity, and interpretation strategies of sequence detection, need to be addressed. In this report, we demonstrate an approach that combines the use of a custom-designed Affymetrix resequencing Respiratory Pathogen Microarray (RPM v.1) with methods for microbial nucleic acid enrichment, random nucleic acid amplification, and automated sequence similarity searching for broad-spectrum respiratory pathogen surveillance. Successful proof-of-concept experiments, utilizing clinical samples obtained from patients presenting adenovirus or influenza virus-induced febrile respiratory illness (FRI), demonstrate the ability of this approach for correct species- and strain-level identification with unambiguous statistical interpretation at clinically relevant sensitivity levels. Our results underscore the feasibility of using this approach to expedite the early surveillance of diseases, and provide new information on the incidence of multiple pathogens.
机译:公共领域数据库中可用的病原体核酸序列呈指数增长,已将其直接用于病原体检测,鉴定和监视策略。 DNA微阵列技术为直接对感兴趣的各种病原体进行DNA序列分析提供了潜力。然而,为了实现这种潜力的实际实现,需要解决许多技术问题,尤其是核酸扩增,探针特异性和序列检测的解释策略。在本报告中,我们展示了一种结合使用定制设计的Affymetrix重排呼吸道病原体微阵列(RPM v.1)的方法与微生物核酸富集,随机核酸扩增和自动序列相似性搜索广谱方法的方法呼吸道病原体监测。成功的概念验证实验,利用从存在腺病毒或流感病毒引起的高热呼吸道疾病(FRI)的患者中获得的临床样本,证明了该方法具有正确的物种和菌株水平鉴定的能力,并且在临床上具有明确的统计解释敏感性水平。我们的结果强调了使用这种方法加快疾病早期监测的可行性,并提供了有关多种病原体发生率的新信息。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号